Filing Details
- Accession Number:
- 0001415889-24-027348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-20 16:20:04
- Reporting Period:
- 2024-11-19
- Accepted Time:
- 2024-11-20 16:20:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590102 | Anand Mehra | C/O Aclaris Therapeutics, Inc. 701 Lee Road, Suite 103 Wayne PA 19087 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-19 | 666,666 | $2.25 | 710,030 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares of Common Stock of the Issuer acquired from the Issuer pursuant to Rule 16b-3(d).
Billionaire Hedge Funds
